×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
European Lung Cancer Congress 2022
Final Programme PDF
Advanced Search
30.03.2022
31.03.2022
01.04.2022
02.04.2022
Educational session
Industry Satellite Symposium
Keynote lecture
Multidisciplinary Tumour Board
Proffered Paper session
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
Congress Hall
13:45(30m)
Heine Hansen Award ELCC 2022
16:30(1h 30m)
Thymic tumours
14:30(1h 30m)
What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC
Forum Hall
18:15(1h 30m)
Bristol Myers Squibb - Breaking barriers in thoracic cancers: The expanding possibilities for patients with I-O treatment
11:30(1h 30m)
Mirati Therapeutics, Inc. - Tailoring therapy: Emerging treatment options in NSCLC
14:30(1h 30m)
Not so small anymore: New therapies and cutting-edge science to guide the care of patients with small cell lung cancer
16:30(1h 30m)
Proffered Paper session 1
South Hall 2
11:30(1h 30m)
Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
14:30(1h 30m)
Implementation of screening programs in Europe
16:30(1h 30m)
New insights in the treatment of geriatric patients
18:15(1h 30m)
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events